Berlin-Buch. The health location.

For one hundred years, physicians and researchers collaborating at Berlin-Buch have been devoted to advancing health.
Here you are invited to learn about Berlin-Buch and its partners and to become acquainted with the unique atmosphere of the campus where the medicine of the future is being created.
Berlin-Buch – dedicated to health
Outstanding hospitals and excellent achievements in basic biomedical research have long been hallmarks of Berlin-Buch. The internationally renowned location for science and health care provision is one of the major players in the health industry cluster in the capital city region.
In line with its clear focus on biomedicine, the Berlin-Buch location offers life science companies and research institutions unique conditions for synergies and for value creation networks. Here clinicians and basic researchers collaborate in joint projects to apply new insights gained in the high-tech laboratories to patient care. New discoveries are available to patients at Berlin-Buch already in the stage of clinical trials.
The promotion and preservation of health is the overarching goal of the circa 6500 people who work at Berlin-Buch – among them scientists of world renown, highly motivated physicians, teachers in the health professions and innovative entrepreneurs.
News Buch Berlin
Not all heart inflammation is the same
A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis. T...
more ...When blood cancer starts to spread
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Sci...
more ...U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer Therapy
225Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma
more ...